RxSight, Inc.RXSTNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+14.1%
5Y CAGR+11.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+14.1%/yr
Annual compound
5Y CAGR
+11.9%/yr
Consistent
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $38.55M | +12.2% |
| 2024 | $34.37M | +18.3% |
| 2023 | $29.05M | +11.8% |
| 2022 | $25.98M | +6.0% |
| 2021 | $24.50M | +11.7% |
| 2020 | $21.93M | -25.8% |
| 2019 | $29.57M | - |